Patterns of Remdesivir Initiation in Immunocompromised Patients Hospitalized With COVID-19

Challenge

Immunocompromised patients hospitalized with COVID-19 face heightened risk of disease progression but patterns of remdesivir initiation in this vulnerable subgroup had not been characterized in real-world US hospital data.

Solution

Target RWE researchers analyzed hospital data to describe patterns of remdesivir initiation timing, dose, and duration among immunocompromised patients hospitalized with COVID-19.